Carcinoma of esophagus
MONDO:0019086Esophageal carcinoma (EC) is a tumor arising in the epithelial cells lining the esophagus and can be divided into two subtypes: esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC).
Also known as: Esophageal cancer, carcinoma of esophagus, carcinoma of the esophagus, carcinoma of the oesophagus, esophageal carcinoma, esophagus carcinoma, oesophagus carcinoma, cancer of esophagus
3352 clinical trials for this condition and its sub-types, 76 tagged with Carcinoma of esophagus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Carcinoma of esophagus
-
Esophageal squamous cell carcinoma 306 trials · 307 incl. sub-types
4 sub-types
- Esophageal adenosquamous carcinoma 3 trials
- Undifferentiated carcinoma of esophagus 1 trial
- Esophageal basaloid carcinoma 0 trials
- Esophagus verrucous carcinoma 0 trials
-
Esophageal adenocarcinoma 170 trials · 174 incl. sub-types
3 sub-types
- Barrett adenocarcinoma 6 trials
- Esophageal adenoid cystic carcinoma 0 trials
- Mucoepidermoid esophageal carcinoma 0 trials
-
Esophagus carcinoma in situ 13 trials
-
New drug combos aim to boost survival in Hard-to-Treat cancers
Disease control Stopped earlyThis study tested several immunotherapy-based drug combinations in 214 people with advanced stomach, gastroesophageal junction, or esophageal cancer that could not be removed by surgery or had spread. Participants received either standard chemotherapy or chemotherapy plus the imm…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new nucleotide analogue boost cancer treatment?
Disease control Stopped earlyThis trial is testing an experimental drug called NUC-3373, a nucleotide analogue, in combination with standard cancer drugs for people with advanced solid tumors. The study has two parts: one combining NUC-3373 with pembrolizumab, and the other combining it with docetaxel. The g…
Phase 1/2 • Sponsor: NuCana plc • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New scan may reveal if cancer treatment is working
Knowledge-focused Stopped earlyThis study is testing whether a special PET scan called 18F-FSPG can help doctors see how well chemotherapy and radiation are working in people with esophageal cancer. Nine adults with untreated, locally advanced esophageal cancer will get the scan before and during treatment. Th…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC